本文实验设计构思介绍
The deposition of amyloid β-protein (Aβ) is one of the major hallmarks of Alzheimer’s disease (AD) pathology. Urokinase-type plasminogen activator (uPA) is involved in plasmin proteolytic cascade, and can be activated by Aβ aggregates, plasmin plays a primary role in the degradation of both monomeric and oligomeric forms of Aβ. The gene, encoding uPA, is called PLAU (plasminogen activator urinary), it is located on chromosome 10q22.2, close to the regions showing linkage to AD. PLAU represents as a strong biologic and positional candidate for AD susceptibility. To determine whether the PLAU gene is genetically associated with sporadic Alzheimer’s disease (SAD) in the Chinese Han population, we examined a missense C/T single nucleotide polymorphism in codon 141 of PLAU (P141L) in patients with SAD and healthy controls。